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The influence of peripheral vascular disease on the
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Aim: Aortic and carotid stiffness is elevated in patients with abdominal aortic aneurysm (AAA). Peripheral vascular
disease (PVD) frequently coexists with AAA and may further impair the arterial wall mechanics and increase the
cardiovascular load. We therefore studied the elastic carotid and muscular femoral biomechanical properties and
intima-media thickness (IMT) in this group of patients.
Methods: The elastic indices and IMTs of the common carotid and common femoral arteries were determined in 30
patients with AAA (15 with PVD) with a duplex scanner coupled with a wall tracking system. Fasting plasma creatinine
level, glucose and lipid concentrations, and their physiologic variables known to influence the arterial wall mechanics were
also assessed.
Results: Patients with AAA and PVD have significantly stiffer carotid (Petersen’s elastic modulus, 2207  905 mm Hg
versus 1268  432 mm Hg; P  .001; stiffness index, 22.73  9.63 versus 12.60  4.24; P  .001] and femoral
(Petersen’s elastic modulus, 4906 4057 mm Hg versus 2599 1169 mm Hg; P .043; stiffness index, 49.02 40.04
versus 26.07 13.22; P .044) arteries than subjects with AAA alone. Although patients with PVD have thicker carotid
and femoral IMTs, no statistical difference was seen between the two groups. The subjects were matched for age, body
mass index, heart rate, systolic and diastolic blood pressures, total vascular risk score, plasma creatinine level, and fasting
lipid and glucose concentrations.
Conclusion: Subjects with PVD and AAA have significantly stiffer carotid and femoral arteries, which may indicate
increased cardiovascular load and may account for the highest mortality rate seen in these patients in the UK Small
Aneurysm Trial. Therefore, treatment of associated cardiovascular risk factors is important and may have to be tailored
on an individual basis according to the findings of the arterial wall mechanics. (J Vasc Surg 2003;37:403-9.)
Abdominal aortic aneurysm (AAA) is a relatively com-
mon coincidental finding in subjects with peripheral vascu-
lar disease (PVD) of the lower extremity.1 In one observa-
tional study of 561 consecutive patients with PVD, the
prevalence of AAA was 9.4%.1 The pathogenesis of AAA is
different from that of PVD.2 In AAA, the loss of elastin in
the aortic wall is thought to be the key event thereby
shifting the pressure load to the collagen fibers.2 This
change in the aortic wall matrix produces alteration in the
elastic properties.3-7 The association of AAA with periph-
eral aneurysmal disease,8 the link with increased metallo-
proteinase activity,9-11 and evidence of a relationship with
polymorphic variation in the fibrillin-1 gene12 support the
hypothesis that AAA is a generalized dilating diathesis and
explain the observed alteration in both the carotid and
aortic biomechanical properties.5,13 Increased carotid stiff-
ness is also significantly correlated to elevated aortic stiff-
ness in an observational study of 121 patients with AAA.5
Therefore, measurement of the carotid wall mechanics may
provide the same information as the aortic assessment and is
technically easier in patients with high body mass index.
The UK Small Aneurysm Trial14 has shown that pa-
tients with an ankle-brachial pressure index (ABPI) of less
than 0.87 had the highest mortality risk from both cardio-
vascular and all causes. Despite the frequent occurrence of
these two conditions together,1 the effect of coincidental
PVD on the carotid and femoral biomechanical properties
and intima-media thickness (IMT) in AAA subjects is un-
known. The presence of PVD may further impair the
already elevated carotid stiffness in subjects with AAA. We
therefore undertook a study to determine the biomechani-
cal properties of the carotid (elastic) and femoral (muscu-
lar) arteries in this selected group of patients at high risk.
METHODS AND MATERIALS
Subjects. This research protocol has been approved
by the locally appointed ethics committee and conformed
to the principles outlined in the Declaration of Helsinki.
Thirty subjects with AAA (4.5 cm), 15 of whom had PVD
(group 1) and 15 of whom were free of PVD (group 2),
were recruited prospectively. All participants were inpa-
tients from a general surgical ward of a teaching hospital.
They were admitted for investigation of AAA before surgi-
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cal or endovascular intervention. No exclusion criteria were
used in the recruitment of these participants. Definition of
PVD was an ABPI of less than 0.915 as measured with an
8-MHz continuous-wave Doppler probe (Huntleigh
500D, Huntleigh Technology, Luton, United Kingdom).
The presumed cardiovascular load assessed on the basis
of a cumulative total vascular risk score (TVRS) was calcu-
lated for all subjects.16,17 This was based on the study by
Lehmann and coworkers17 that showed a significant inverse
relationship between the presumed cardiovascular load (as
assessed by the number of cardiovascular risk factors/
events) and aortic compliance. Although no proper weight-
ing has been applied, we believed that this was an important
finding as increasing risk factors and events were associated
with decreasing arterial compliance. Therefore, this was
one method that we could use to adjust the cardiovascular
load equally in our study groups, although we had not
formally assessed our modified scoring system. The original
risk factors and events included: diabetes mellitus, hyper-
tension, smoking, cerebrovascular/transient ischemic
event, myocardial infarction, angina, and PVD. We have
therefore modified this TVRS to include hypercholesterol-
aemia and renal impairment and to exclude PVD in this
study. All these factors are known to alter arterial wall
mechanics and thickness. These risk factors and events were
as follows: 1, current cigarette smoking or former smoker
within the last 12 months; 2, history of hypertension on
medication; 3, history of hypercholesterolemia on medica-
tion; 4, history of diabetes mellitus; 5, history of ischemic
heart disease; 6, history of stroke, transient ischemic attack,
or known carotid stenosis 70%; and 7, renal impairment.
Measurements. After informed consent was given,
the body mass index of all subjects was calculated. They
then were rested for 15 minutes in the supine position
before the noninvasive measurement of the pulse and blood
pressure with an automated blood pressure monitor (Dy-
namap Compact TS, Johnson & Johnson Medical, New-
port, United Kingdom) applied to the right brachial artery.
In addition, measurements of fasting plasma cholesterol,
triglyceride, creatinine, and glucose were also undertaken
at the end of the ultrasonic measurement.
Electrocardiographic leads were placed on the chest
wall for R-wave triggered measurements of the elastic be-
havior and IMT. Real-time B-mode and M-mode images of
the arterial wall motion were recorded with a 7.5-MHz
linear array probe linked to a specially adapted duplex
ultrasound scanning system (Pie 350, Pie Medical Sys-
tems). The side of the recording was chosen such that it was
the asymptomatic leg or the leg with the highest ABPI in
the case of femoral measurement and the asymptomatic
side or the side with the lowest degree of stenosis for the
carotid recording. Measurements were made in the sagittal
plane at 90 degrees to the long axis of the artery with signal
output to a high-resolution, echo-locked wall tracking
system (Wall Track, Pie Medical Systems).16,18 This system
allowed measurement of the intraluminal diameter over
time with automatic tracking of the assigned points repre-
senting the anterior and posterior vessel walls (Fig 1). The
sampling rate of computation of the intraluminal diameter
was approximately 200 Hz. It also recorded the IMT
automatically as defined by the double line pattern corre-
sponding to the lumen-intima and media-adventitia inter-
faces (Fig 2).19,20
The intraluminal diameter and IMT were recorded
three times from the common carotid and common femo-
ral arteries within 3 cm of the bifurcation. We chose an area
of the vessel where there was no visible plaque. Each
recording was programmed to last for 2 seconds to catch at
least one R wave-trigger reading and not to distort the
results by prolonged tracking of the specific part of the
vessel. The average of the three recordings was taken as the
mean IMT and the mean systolic and diastolic intraluminal
diameters. One sonographer performed all the measure-
ments.
Theoretic considerations. No universally recognized
convention exists for the categorization of arterial viscoelas-
tic properties. This is largely because of the complex nature
of the human arterial system. There is considerable varia-
tion in not only the biophysical and biochemical properties
of different vessels but also in the pressure wave as it travels
along the arterial system, where it is met by wave reflection
from terminal arterioles. In an attempt to understand the
complex biophysics of blood vessels in vivo, a variety of
measurements has been derived.21-23 Petersen’s elastic
modulus (Ep) is defined as24:
Ep(mm Hg) 
Dd(Ps  Pd)
(Ds  Dd)
where D and P are diameter and pressure and s and d
denote systole and diastole, respectively. The inverse of Ep
is known as the diametric or cross-sectional compliance (C)
and is given by the equation:
C(%mm Hg1  102) 
(DsDd)
Dd(PsPd)
 104
They measure the fractional change rather than the
absolute change in the viscoelastic properties of the artery.
This provides a means with which arteries of varying diam-
eters can be compared. The stiffness index () has been
shown to be less dependent on the arterial blood pressure
than the elastic modulus25 and is given by the equation:
 
[loge(Ps  Ps)]Dd
(Ds  Dd)
.
In this study, we computed all three indices to assess
the elastic properties of the carotid and femoral arteries to
avoid bias towards any of the parameters.
Data analysis and statistical methods. The biome-
chanical indices, intraluminal diameter, and IMT of the
common carotid and common femoral arteries were com-
pared with the two-tailed independent (unpaired) t test
assuming equal variance between the two groups. The same
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test was used to compare the physiologic parameters and
biochemical findings of the two groups.
A general linear model was applied to estimate differ-
ences in means in the elastic, IMT, intraluminal diameter,
and luminal distension variables between the two groups,
both before and after adjustment for potentially influential
variables, which in this study were the age, diastolic pres-
sure, and TVRS, as there was a suggestion that they might
be significant.
Intraobserver errors were determined with the intra-
class correlation coefficients (ICC). The interobserver error
has been determined in this unit in previous study with an
ICC between 0.88 to 0.91 for carotid and femoral disten-
sions and 0.89 for carotid and femoral IMT measure-
ments.16 All statistical analyses were performed with SPSS
for Windows (version 10.05, SPSS Inc, Chicago, Ill) statis-
tical package. Data are shown as mean  standard devia-
tion.
Fig 1. B-mode and M-mode images of common carotid artery in healthy subject (A); typical radiofrequency signal
acquired from artery analyzed to locate and mark anterior and posterior luminal surfaces (B); vessel distension over four
cardiac cycles displayed (C).
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RESULTS
The patient characteristics of the two groups are de-
fined in Table I. The two groups were matched in known
determinants of arterial elastic behavior and IMT, includ-
ing age, body mass index, heart rate, systolic and diastolic
blood pressures, cardiovascular load, plasma creatinine,
fasting lipids, and glucose.
Subjects with both AAA and PVD had significantly
stiffer carotid arteries (C, 5.26  2.00% mm Hg1102
versus 8.75  2.82% mm Hg1102; P  .001; Ep,
2207 905 mm Hg versus 1268 432 mm Hg; P .001;
, 22.73  9.63 versus 12.60  4.24; P  .001) and
femoral arteries (Ep, 4906  4057 mm Hg versus 2599 
1169 mm Hg; P .043; , 49.02 40.04 versus 26.07
13.22; P .044) than patients with AAA alone. Even after
adjustment for age, diastolic pressure, and cardiovascular
load, the results remained highly significant (Table II).
Only the femoral Ep and  showed significance, rather than
the compliance index. This was rather odd as Ep is basically
the reciprocal value of the diametric compliance. This was
explained with the box and whiskers plots, which showed
that the variance was different between the two groups.
With the Student t test, we assumed that the variance was
equal between the groups. An alternative test would be the
Mann-Whitney nonparametric test based on rank. How-
ever, if we used this test, we would not be able to made
adjustment to the physiologic and biochemical parameters,
which we could do with the t test. Hence, we have kept the
t test results.
The carotid artery did not show any significance differ-
ence in the luminal diameter, but the femoral systolic and
diastolic diameters (systolic, 9.51  2.02 mm versus
Fig 2. Double line pattern representing IMT complex of far carotid wall. Distance density curve has been generated
automatically from radio frequency signal, and distance between markers (lumen-intima and media-adventitia inter-
faces) represent IMT (in this case, 0.70 mm).
Table I. Patient characteristics between two groups
Characteristics Group 1 (PVD and AAA) Group 2 (AAA only) P value
Gender 13M, 2F 15M
Age (y) 74.93  5.95 71.53  6.62 .150
BMI (kgm–2) 29.33  4.30 29.06  4.24 .865
Heart rate (bpm) 74.40  12.28 72.60  13.07 .700
Systolic BP (mm Hg) 134.00  20.49 129.53  23.90 .587
Diastolic BP (mm Hg) 71.00  12.74 80.07  11.99 .055
TVRS 2.07  1.16 2.27  1.39 .672
Creatinine (molL–1) 120.93  32.62 110.60  25.98 .345
Cholesterol (mmolL–1) 5.59  1.81 4.72  1.74 .192
Triglyceride (mmolL–1) 1.78  0.67 2.42  2.72 .388
Glucose (mmolL–1) 6.13  1.98 6.17  2.46 .955
PVD denotes peripheral vascular disease, and AAA represents abdominal aortic aneurysm.
M, Male; F, female; BMI, body mass index; BP, blood pressure.
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11.23 2.35 mm for AAA/PVD and AAA groups, respec-
tively; P .040; diastolic, 9.28 1.92 mm versus 10.98
2.26 mm; P  .035) were significantly larger in patients
with AAA alone (Table III). However, after adjustment for
age diastolic pressure and cardiovascular load, these results
just failed to show significance.
Although the IMT of the carotid (0.81  0.25 mm
versus 0.69 0.25 mm; P .22) and femoral (1.07 0.33
mm versus 0.89 0.42 mm; P .19) arteries were thicker
in subjects with PVD and AAA, no statistically significant
difference was seen between the two groups (Table II). The
ICC for carotid and femoral distension and IMT measure-
ments varied from 0.89 to 0.95, indicating a high degree of
correlation between these measurements.
DISCUSSION
The pathogenesis of AAA is multifactorial2; however,
the key event has been suggested to be the loss of elastin
from the aortic wall.2,26 This is the result of increased
elastinolytic activity of the metalloproteinases, particularly
metalloproteinase-2 and metalloproteinase-9, in the aortic
wall.9,10 It has been suggested that metalloproteinase-9
level may be related to the size and rupture of AAA.11 Loss
of elastin from the aortic wall means the remaining collagen
fibers have to endure the force of the blood pressure, which
leads to alteration in the wall mechanics.4-6 This was shown
in an observational study of 30 patients with AAA whose
aortic stiffness (Ep) was significantly increased, which cor-
related with reduced elastin content from the aortic biop-
sy.4 This was further supported by two larger studies.3,5
Sonesson, Hansen, and Lanne5 showed significantly stiffer
aortas in 121 men and women with AAA in comparison
with healthy individuals from publications elsewhere. Wil-
son and coworkers3 have shown significant inverse relation-
ships between the aortic elastic properties (Ep and ) and
serum elastin peptides and 	-1 antitrypsin complex, which
indicated elastolysis, in 62 asymptomatic patients with
AAA.3 Furthermore, they also showed a positive correla-
tion between these elastic parameters and procollagen III-
N-terminal propeptide, which indicated an increased colla-
gen turnover.
The effect of PVD on the elastic properties and IMT of
the carotid and femoral arteries in patients with AAA is not
known. One study has shown the little effect PVD had in
patients with normal diameter aorta4 rather than with AAA.
The UK Small Aneurysm Trial has shown that subjects with
an ABPI of less than 0.87 have the highest mortality risk,14
and it is not uncommon to find that PVD and AAA coex-
Table II. Elastic properties (diametric compliance, Ep, and ) and IMT of common carotid and common femoral
arteries for PVD and AAA and AAA only groups (mean  standard deviation)
PVD and
AAA AAA only
Unadjusted Adjusted*
Difference in mean
(95% CI)
P
value
Difference in mean
(95% CI)
P
value
Elastic index
CCA, C (%mm Hg–1  10–2) 5.26  2.00 8.75  2.82 –3.49 (–5.33 to –1.66) .001 –3.36 (–5.53 to –1.58) .001
CCA, Ep (mm Hg) 2207  905 1268  432 938 (408 to 1469) .001 1050 (509 to 1591) 
.001
CCA,  22.7  9.63 12.6  4.24 10.1 (4.6 to 15.7) .001 11.3 (5.6 to 17.0) 
.001
CFA, C (%mm Hg–1  10–2) 4.09  3.50 4.64  2.18 –0.55 (–2.74 to 1.63) .61 –0.94 (–3.23 to 1.35) .41
CFA, Ep (mm Hg) 4906  4057 2599  1169 2307 (74 to 4540) .043 2528 (140 to 4917) .039
CFA,  49.0  40.0 26.1  13.2 23.0 (0.65 to 45.3) .044 25.4 (1.61 to 49.2) .037
IMT
CCA (mm) 0.80  0.25 0.69  0.25 0.11 (–0.07 to 0.30) .22 0.13 (–0.06 to 0.31) .16
CFA (mm) 1.07  0.33 0.89  0.42 0.19 (–0.10 to 0.47) .19 0.21 (–0.09 to 0.51) .16
*Adjusted for age, diastolic pressure, and total cardiovascular risk score.
CCA, Common carotid artery; CFA, common femoral artery.
Table III. Intraluminal diameters of common carotid and common femoral arteries for PVD and AAA and AAA only
groups (mean  standard deviation)
Elastic index
PVD and
AAA AAA only
Unadjusted Adjusted*
Difference in mean
(95% CI) P value
Difference in mean
(95% CI) P value
Carotid systolic diameter (mm) 8.99  1.71 8.85  1.14 0.14 (–0.95 to 1.23) .8 0.39 (–0.72 to 1.50) .5
Carotid diastolic diameter (mm) 8.71  1.68 8.51  1.11 0.20 (–0.87 to 1.27) .7 0.45 (–0.64 to 1.54) .4
Change in carotid diameter (mm) 0.28  0.12) 0.34  0.13 –0.05 (–0.15 to 0.04) .2 –0.05 (–0.15 to 0.05) .3
Femoral systolic diameter (mm) 9.51  2.02 11.23  2.35 –1.72 (–3.36 to –0.08) .04 –1.53 (–3.26 to 0.19) .08
Femoral diastolic diameter (mm) 9.28  1.92 10.98  2.26 –1.70 (–3.27 to –0.13) .035 –1.50 (–3.15 to 0.15) .07
Change in femoral diameter (mm) 0.23  0.19 0.21  0.12 0.01 (–0.10 to 0.13) .8 0.01 (–0.12 to 0.13) .9
*Adjusted for age, diastolic pressure, and total cardiovascular risk score.
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ist.1,27 Therefore, determination of whether subjects with
both PVD and AAA had increased stiffness/elasticity is
important because there is increasing evidence that im-
paired arterial elastic properties are associated with cardio-
vascular risks and events.25,28-33 They have been shown to
be independently associated with smoking,28 diabetes mel-
litus,30 hypertension,32 hypercholesterolemia,34 coronary
heart disease,25 stroke,31 and renal failure.33 These biome-
chanical properties are being recognized as good markers of
atherosclerosis and increasing cardiovascular load.23,35
Furthermore, some evidence exists that treatment of these
risk factors result in improved biomechanical proper-
ties36-39 and better clinical outcome.40
Our results have shown a significant reduction in the
elastic carotid and muscular femoral biomechanical proper-
ties in patients with AAA, who also had PVD, compared
with subjects with AAA free of PVD. This association was
shown when matched for known determinants of elastic
properties, including: age, body mass index, heart rate,
systolic blood pressure, diastolic blood pressure, presumed
cardiovascular load, plasma creatinine level, fasting choles-
terol, triglycerides, and glucose concentrations. The im-
paired arterial wall mechanics in these patients may imply
increased cardiovascular load and may account for highest
mortality risk seen in the UK Small Aneurysm Trial.14
AAA has been suggested as a generalized dilating dia-
thesis caused by an increased collagen and decreased elastin
in the arterial wall matrix, and the aorta is the area where the
disease shows its clinical manifestation.26,41 This theory is
supported by observation that nonaneurysmal aortic seg-
ments have significantly greater collagen and lower elastin
contents26 and the mean diameters of peripheral arteries are
significantly larger in patients with AAA.41 We have shown
that the femoral artery is significantly larger in subjects with
AAA without evidence of PVD. However, after adjustment
for age, diastolic pressure, and TVRS, this just failed to
make significance.
The hereditary nature of some AAAs, its association
with peripheral artery aneurysm,8 and its relationship with
polymorphic variation of the fibrillin-1 gene12 explain the
impaired wall mechanics of the carotid artery and the
aorta5,13 in subjects with AAA. PVD seems to enhance the
generalized arterial stiffness associated with AAA. The
greatest difference is seen in the carotid artery rather than
the femoral artery in our study. One explanation may be the
fact that the carotid is an elastic artery and the femoral is a
muscular one.
The advantages of the duplex scan method are that it is
a noninvasive technique and specific segments of an indi-
vidual artery can be assessed. However, it is limited by the
ability of the Wall Track system to recognize the anterior
and posterior walls, the reproducibility of the measure-
ments, and the problem of obtaining accurate blood pres-
sure measurement at the point of interest.
Ideally, the blood pressures and intraluminal diameters
should be measured from the arterial segment concerned.
However, this would then become an invasive technique
with its associated complications and ethically not feasible.
We have therefore chosen to use the brachial pressure as the
reference pressure because it is more accessible than either
the carotid or femoral artery. This approach has the prob-
lem that the pulse pressure increases by around 18% to 31%
from the aorta to the brachial artery.42,43 This is the result
of wave reflection from the periphery leading to augmen-
tation of the peak pressure wave in the peripheral arteries
close to the reflection sites.44 However, this increase in the
pulse pressure mainly occurs in the healthy and young
subjects with elastic arteries, and with advancing age, the
pulse wave velocity increases so that the augmentation
phenomenon also occurs in the central arteries.45 Thus, the
differences in the pulse pressure between central and pe-
ripheral arteries diminish with age and disappear in the
middle-aged and elderly subjects. Several groups have
shown the validity of this approach,46-48 and this has been
used in published research.25,30,49
Detection of impaired biomechanical properties in sub-
jects with AAA and PVD should alert the vascular surgeon
and angiologist to treat associated risk factors, such as
smoking, hypertension, diabetes, and hyperlipidemia, more
aggressively because these patients have the highest all-
cause and cardiovascular mortality risk. Risk factor modifi-
cation may have to be tailored to the individual need.
Biomechanical properties may therefore help to differenti-
ate between individuals at high risk and low risk.
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